The Federal Trade Commission said the three companies' practices have artificially inflated list prices for insulin.
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients. Three companies that ...
The first big update to U.S. methadone regulations in 20 years is poised to expand access to the life-saving drug starting ...